featured
G-CSF Primary Prophylaxis May Improve Outcomes in Newly Diagnosed Stage III/IV Hodgkin Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Primary Prophylaxis With G-CSF May Improve Outcomes in Patients With Newly Diagnosed Stage III/IV Hodgkin Lymphoma Treated With Brentuximab Vedotin Plus Chemotherapy
Leukemia and Lymphoma 2020 Aug 25;[EPub Ahead of Print], D Straus, G Collins, J Walewski, PL Zinzani, A Grigg, A Sureda, A Illes, TM Kim, S Alekseev, L Specht, V Buccheri, A Younes, J Connors, A Forero-Torres, K Fenton, A Gautam, I Purevjal, R Liu, A GallaminiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.